$TRVI Trevi Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Trevi Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Trevi Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Trevi Therapeutics, Inc. for free.

CIK Number: 0001563880
IRS Number: 450834299
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TRVI
Company Address: 195 CHURCH STREET 14TH FLOOR NEW HAVEN 06510
Phone number: 203-304-2499

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good in March 2011 and is headquartered in New Haven, CT.

Trevi Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 15 2021TRVITrevi Therapeutics ...Galletta ChristopherSee RemarksOption ExerciseA2.5325,00063,25025,000
Feb 03 2021TRVITrevi Therapeutics ...Forbes William PChief Development O ...Option ExerciseA3.03200,000606,000200,000
Jul 01 2020TRVITrevi Therapeutics ...Colangelo DominickDirectorOption ExerciseA6.8723,684162,70923,684
Jun 15 2020TRVITrevi Therapeutics ...Mathers Edward TDirectorOption ExerciseA4.1014,21058,26114,210
Jun 15 2020TRVITrevi Therapeutics ...VANLENT ANNEDirectorOption ExerciseA4.1014,21058,26114,210
Jun 15 2020TRVITrevi Therapeutics ...Heffernan Michael ThomasDirectorOption ExerciseA4.1014,21058,26114,210
Jun 15 2020TRVITrevi Therapeutics ...Meeker David PDirectorOption ExerciseA4.1014,21058,26114,210
Apr 13 2020TRVITrevi Therapeutics ...Walker Paul Edward10% OwnerOption ExerciseX0.001,500,0001,5000
Apr 13 2020TRVITrevi Therapeutics ...Walker Paul Edward10% OwnerSellS2.665641,5005,937,9985.9 M to 5.9 M (-0.01 %)
Apr 13 2020TRVITrevi Therapeutics ...Walker Paul Edward10% OwnerBuyX0.001,500,0001,5005,938,5624.4 M to 5.9 M (+33.79 %)
Apr 13 2020TRVITrevi Therapeutics ...Sonsini Peter W.10% OwnerOption ExerciseX0.001,500,0001,5000
Apr 13 2020TRVITrevi Therapeutics ...Sonsini Peter W.10% OwnerSellS2.665641,5005,937,9985.9 M to 5.9 M (-0.01 %)
Apr 13 2020TRVITrevi Therapeutics ...Sonsini Peter W.10% OwnerBuyX0.001,500,0001,5005,938,5624.4 M to 5.9 M (+33.79 %)
Apr 13 2020TRVITrevi Therapeutics ...SANDELL SCOTT D10% OwnerOption ExerciseX0.001,500,0001,5000
Apr 13 2020TRVITrevi Therapeutics ...SANDELL SCOTT D10% OwnerSellS2.665641,5005,937,9985.9 M to 5.9 M (-0.01 %)

View all Trevi Therapeutics, Inc. insider transactions.